• Record: found
  • Abstract: found
  • Article: not found

Magnesium substitution and postoperative arrhythmias in patients undergoing coronary artery bypass grafting.

Scandinavian Cardiovascular Journal

Atrial Fibrillation, epidemiology, prevention & control, Atrial Flutter, Coronary Artery Bypass, Humans, Incidence, Magnesium Sulfate, therapeutic use, Male, Middle Aged, Postoperative Complications, Time Factors, Water-Electrolyte Imbalance

Read this article at

      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


      Sixty coronary artery bypass grafting patients were randomized to receive either magnesium sulphate or placebo for 4 days postoperatively. The magnesium substitution reduced the duration of atrial fibrillation or flutter (p < 0.05), but not the number of patients developing these arrhythmias. The number of ventricular ectopic beats was also reduced among patients receiving magnesium sulphate compared to placebo (p < 0.05). To evaluate whether the anti-arrhythmic effect of magnesium sulphate was explained by a faster resumption of cellular potassium postoperatively, skeletal muscle electrolyte concentrations were measured pre-operatively and on the third day postoperatively. No significant difference was found in skeletal muscle potassium or magnesium contents on the third day postoperatively when comparing the two groups. The serum magnesium level declined postoperatively in the placebo group, whereas an increase was found in patients receiving magnesium sulphate. We suggest magnesium substitution as a routine postoperatively, because this treatment seems to reduce the severity of postoperative arrhythmias.

      Related collections

      Author and article information



      Comment on this article